ProShares Ultra NASDAQ Biotechnology
24 hedge funds and large institutions have $11.6M invested in ProShares Ultra NASDAQ Biotechnology in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 7 closing their positions.
Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
7
Closed
7
Calls
$2.54M
Puts
$2.24M
Net Calls
+$303K
Net Calls Change
-$380K